Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing
Pharmaceutics · 03.09.2024 · 16 (9) · 1160
DOI: 10.3390/pharmaceutics16091160 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 03.09.2024. Verfasst von Sanchaita Rajkhowa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh 786004, Assam, India. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imam Mohammad Ibn Saud Islamic University.
Abstract (Originalsprache)
The increase in antibiotic-resistant bacteria presents a significant risk to worldwide public health, emphasizing the necessity of novel approaches to address infections. Quorum sensing, an essential method of communication among bacteria, controls activities like the formation of biofilms, the production of virulence factors, and the synthesis of secondary metabolites according to the number of individuals in the population. Quorum quenching, which interferes with these processes, emerges as a vital approach to diminish bacterial virulence and prevent biofilm formation. Nanocarriers, characterized by their small size, high surface-area-to-volume ratio, and modifiable surface chemistry, offer a versatile platform for the disruption of bacterial communication by targeting various stages within the quorum sensing pathway. These features allow nanocarriers to infiltrate biofilms, disrupt cell membranes, and inhibit bacterial proliferation, presenting a promising alternative to traditional antibiotics. Integrating nanocarrier-based systems into combination therapies provides a multi-pronged approach to infection control, enhancing both the efficacy and specificity of treatment regimens. Nonetheless, challenges related to the stability, safety, and clinical effectiveness of nanomaterial-based antimicrobial treatments remain. Continued research and development are essential to overcoming these obstacles and fully harnessing the potential of nano-antimicrobial therapies. This review emphasizes the importance of quorum sensing in bacterial behavior and highlights the transformative potential of nanotechnology in advancing antimicrobial treatments, offering innovative solutions to combat antibiotic-resistant pathogens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh 786004, Assam, India.
- Department of Chemistry, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.
ORCID-Profile: Sanchaita Rajkhowa, Safrina Zeenat Hussain, Manisha Agarwal, Alaiha Zaheen, Magdi E A Zaki
Förderung
- Imam Mohammad Ibn Saud Islamic University
Zitieren
APA
Rajkhowa, S., Hussain, S. Z., Agarwal, M., Zaheen, A., Al-Hussain, S. A., & Zaki, M. E. A. (2024). Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing. Pharmaceutics, 16(9), 1160. https://doi.org/10.3390/pharmaceutics16091160
Vancouver
Rajkhowa S, Hussain SZ, Agarwal M, Zaheen A, Al-Hussain SA, Zaki MEA. Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing. Pharmaceutics. 2024;16(9):1160. doi:10.3390/pharmaceutics16091160
BibTeX
@article{Rajkhowa2024,
author = {Rajkhowa, Sanchaita and Hussain, Safrina Zeenat and Agarwal, Manisha and Zaheen, Alaiha and Al-Hussain, Sami A and Zaki, Magdi E A},
title = {Advancing Antibiotic-Resistant Microbe Combat: Nanocarrier-Based Systems in Combination Therapy Targeting Quorum Sensing},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {9},
pages = {1160},
doi = {10.3390/pharmaceutics16091160}
}
EUVIMED